176 related articles for article (PubMed ID: 22436788)
1. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
Mikell JK; Klopp AH; Gonzalez GM; Kisling KD; Price MJ; Berner PA; Eifel PJ; Mourtada F
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e417-22. PubMed ID: 22436788
[TBL] [Abstract][Full Text] [Related]
2. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract][Full Text] [Related]
3. SU-E-T-425: Impact of Model Based Dose Calculation Algorithm for Ir-192 Intracavitary Brachytherapy with Shielded Applicator.
Mikell J; Klopp A; Price M; Mourtada F
Med Phys; 2012 Jun; 39(6Part16):3802. PubMed ID: 28517225
[TBL] [Abstract][Full Text] [Related]
4. The dosimetric impact of heterogeneity corrections in high-dose-rate ¹⁹²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans.
Hyer DE; Sheybani A; Jacobson GM; Kim Y
Brachytherapy; 2012; 11(6):515-20. PubMed ID: 22386723
[TBL] [Abstract][Full Text] [Related]
5. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
6. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Kim RY; Shen S; Duan J
Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
[TBL] [Abstract][Full Text] [Related]
7. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
8. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
9. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
[TBL] [Abstract][Full Text] [Related]
10. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
11. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer.
Kim RY; Shen S; Lin HY; Spencer SA; De Los Santos J
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):485-9. PubMed ID: 19467797
[TBL] [Abstract][Full Text] [Related]
12. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
[TBL] [Abstract][Full Text] [Related]
13. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
14. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
15. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
Srivastava AK; Rastogi M; Mishra SP
J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
[TBL] [Abstract][Full Text] [Related]
16. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
18. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
[TBL] [Abstract][Full Text] [Related]
19. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
20. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
